chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Caller reported that he did not feel anything when the second dose of the Covid-19 vaccine was administered; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 26Feb2021 15:00 (Lot number: ER8732) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Blood cholesterol increased" (ongoing), notes: Verbatim: High cholesterol.Cholesterol got bad 2-3 years ago and he started taking medication. The patient took concomitant medications. Vaccination history included: Bnt162b2 (First dose: Date: 05Feb2021; , Lot Number: EN4204; , Anatomical Location: Left arm), administration date: 05Feb2021, for Covid-19 immunization, reaction(s): "Sore arm"; Tetanus shot (Vaccine Name: Tetanus shot, Manufacturer: Unknown, Lot Number: Unknown, Route: Injection, Anatomical Location: Arm, Caller reported that he received the tetanus shot a month or two before the first dose of the Covid-19 vaccine.).The following information was reported: FEELING ABNORMAL (non-serious) with onset 26Feb2021, outcome "unknown", described as "Caller reported that he did not feel anything when the second dose of the Covid-19 vaccine was administered".  Additional information : No Additional Vaccines Administered Vaccines.There was No Emergency Room Visit for any AE(s).Date: Caller reported that he received the tetanus shot a month or two before the first dose of the Covid-19 vaccine.No AE(s) following prior vaccinations were reported.No Family Medical History Relevant to AE(s) was reported. Report filed. Report 1 of 2. Caller was difficult to control and would speak over agent. Multiple attempts were made to redirect and to clarify information provided. Caller was provided with phone number, and reference number, Withheld, prior to transfer.Yes , there is a Product Complaint.Description of Product Complaint:Description of complaint: talcum powder caused cancer and the company was aware of it.  No follow-up attempts are possible. No further information is expected.
Vaccine was given in my left upper underarm. Reaction (which is continuing as of time of report, 3/10/2016) is a hardened reddened area, 2x3 inches, surrounded by slight edema which extends about 1-2 inches beyond the reddened area.  Painful to touch, otherwise slightly itchy.
her right side, her ear felt hot/ face did not have the same amount of hot feeling; Her right side, her ear felt hot, red, and tingled; Her right side, her ear felt hot, red, and tingled/ tingling then proceeded into the right side of her face; slightly numbness and tingling went to the right side of her face; This is a spontaneous report from a contactable consumer (patient). A 51-years-old female patient received BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, batch/lot number, NDC number, expiry date: unknown) via an unspecified route of administration in right arm on 16Mar2021 at 15:45 (at the age of 51 years-old) as dose 1, single for covid-19 immunization. Caller provided EN6208 from her patient record card. Stated that it does not said that it was the lot number. Medical history included Addison's disease, autoimmune disorder, and primary adrenal insufficiency all from an unknown date and unknown if ongoing. On 10Feb2021, she received hepatitis A and B vaccine (unknown lot number, NDC or expiration). History of all previous immunization with the Pfizer vaccine, additional vaccines administered on same date of the Pfizer suspect, prior vaccinations (within 4 weeks), adverse events following prior vaccinations were reported as none. No family medical history relevant to adverse events. Concomitant medications included prednisone (PREDNISONE) taken for Addison's disease, primary adrenal insufficiency, autoimmune disorder from an unspecified start date and ongoing; fludrocortisone (FLUDROCORTISONE) taken for Addison's disease from an unspecified start date and ongoing. She started taking 10 years ago. She stated that this does not really necessarily put her in that category of people who are immune compromised. The patient experienced side effects the same day she received the first dose of the covid vaccine on 16Mar2021, they started 2-3 hours after receiving the vaccine. She stated that on the same side that she got the vaccine, her right side, her ear felt hot, red, and tingled. Clarified that her ear was not numb, but it tingled. Her ear was warm to touch, red and felt hot. The tingling then proceeded into the right side of her face. But her face did not have the same amount of hot feeling. As time went on, she experienced the same tingling sensation, she guesses very very slightly numbness and tingling went to the right side of her face. It was mainly tingling. Her face did not felt hot. It was only tingling and minor warmth. The tingling in her ear and face continued through the evening of 16Mar2021. They were gone by the next morning on 17Mar2021. Duration of reaction/event was 1 day. The patient did not require emergency room or physician office visit. She was concerned to get the second dose of the covid vaccine. She knew that there is not a lot of studies and she wondered if she could anticipate more effects from the second dose of the covid vaccine. No investigation assessment was reported. The outcome of all the events at the time of last observation was resolved on 17Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Walking to my car 15 min after the vaccine, I puked. Had some allergy symptoms and missed work Wednesday, went back to work on Thursday and felt a pain in my neck to fingertips, my coworkers checked my blood pressure and did an EKG, I was fine. 190/119 when I left my job at the hospital, at the hospital I went to after, it was 227/107. Then I was admitted into the hospital, where I stayed one night.
Patient received Moderna on April 14,2021 and was given Pfizer as their second dose on September 8, 2021. At the time, the patient did not have a vaccine card and did not report that she had been given any covid vaccines prior to 9/8/21.
After the 2nd dose my arm was very sore (muscle ache) and fever; After the 2nd dose my arm was very sore (muscle ache) and fever; My arm was very sore; The initial case was missing the following minimum criteria: identifiable patient. Upon receipt of follow-up information on 29Mar2021, this case now contains all required information to be considered valid. This is a spontaneous report from a Pfizer-sponsored program. A contactable male consumer (patient) reported that, A 82-years-old male patient received bnt162b2 (Pfizer-Biontech Covid-19 Vaccine, Solution for injection), dose 2 intramuscular, administered in Arm Left on 22Feb2021 15:30 (Batch/Lot Number: EN6201) as single dose for covid-19 immunisation. Medical history included ongoing COPD (chronic obstructive pulmonary disease) from 2000 and ongoing Enlarged Prostate from 2000. Historical vaccine included bnt162b2 (Pfizer-Biontech Covid-19 Vaccine, Lot number: EL5982) dose 1 Intramuscular, administered in Left Upper Arm on 02Feb2021 1:10 PM for COVID-19 immunisation. Concomitant medication included tiotropium bromide (SPIRIVA) taken for chronic obstructive pulmonary disease from 2000, salbutamol (ALBUTEROL HFA) taken for chronic obstructive pulmonary disease from 2000 and ongoing, budesonide, formoterol fumarate (SYMBICORT) taken for chronic obstructive pulmonary disease from 2000 and ongoing, terazosin (TERAZOSIN) taken for prostatomegaly from 2000 and ongoing and finasteride (FINASTERIDE) taken for prostatomegaly from 2000 and ongoing. The patient experienced after the 2nd dose my arm was very sore (muscle ache) and fever and my arm was very sore on an unspecified date in Feb2021. The patient underwent lab tests and procedures which included positron emission tomogram: unknown on 22Feb2021 Slightly radioactive spinal fluid culture. Outcome of the events was recovered on an unspecified date.  No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a physician refers to a female patient of unknown age. The patient was vaccinated with ZOSTAVAX (lot# was unknown) one years ago in January 2012. No concomitant medications were reported. The reporter reported the patient had a sore shoulder for 1 year after receiving ZOSTAVAX. The shoulder was the same arm as the ZOSTAVAX injection. It did not report whether the patient sought medical attention. No treatment information was reported. The event outcome was unknown at the time of this report. Additional information is not expected.
Had a flushing throughout body a few minutes after  vaccine Had significant dizziness and lightheadedness especially when going from laying down to sitting or standing for about 2 weeks after 2nd vaccine.
patient was given pfizer vaccine that was stored in the freezer past temperature excursion allowed. Patient has NO complaints or adverse events.
On the first day, soreness of the arm and as the evening progressed I started feeling itchiness at the site of the injection. At bed time, started feeling itchy but did not have any visual signs of problematic skin. Felt itchy during my sleep so badly that I scratched my skin during my sleep. Several scratches, bleeding from scratching. Saw bumps (hives) on my skin that morning and started to feel better on Friday but returned on Sunday. Noticed very minor menstrual spotting before going to bed Thursday, November 4. Spotting on Friday, November 5 more than previous day but still minimal, this continued Saturday and Sunday requiring use of light tampon. Woke up to very brief painful cramps Monday November 8 morning and noticed several clots in blood.  My menstrual cycle is typically regular and was not due until November 11, 2021. Nausea was horrible the first few days, and did not start getting better until Sunday evening. Still feeling slight nausea today. Arm soreness continued for 2-3 days, but felt overall soreness especially in lower back, left neck and left shoulder still continues today (Monday, November 8, 2021). Headaches started on first day and won't go away with Tylenol or ibuprofen. Noticed fogginess in thinking, memory, and slower processing speech.
nausea, headache, fever, restlessness, passing out feeling, itchy,rash, ,
headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a male patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) had resolved.            No concomitant were reported. No treatment were reported.   Reporter did not allow further contact
My arm was hurting from elbow all the way to my shoulder. Tingling And then it got It was sore and it stayed in a position where I could not bend it like it was in a cast or sling, it just got stiff. Went the Dr. And he gave me a steroid shot. Said I had a reaction to the vaccine. He claims that where I got the shot they hit a nerve in my arm meaning the shot was too high on the arm.
Patient only administered less than 1/2 of original dose.  Per CDC guidance, appropriate dosing administered in opposite arm.
2/1/2022 18-year-old female received booster shy of 5-month CDC guideline recommendation.  EMT-C16023 miscalculated date and administered booster 14 days before due date.
c/o tingling lt wrist to below 10mins p/vax; returned to hlth dept;no swelling or discoloration @ inj site;no itching;No SOB;on way home 10mins later c/o SOB;mom called ambulance;To ER
pt recvd vax & 4 days later devel soreness & redness @ inj site & exp intermittent pinching sensation from elbow to the wrist; 1 wk p/inj pt c/o h/a & back pain;
Soreness of injection site; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 28-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: unknown), via an unspecified route of administration in the right arm on 19Jan2021 at 06:15 P.M. (at the age of 28-years-old) as a single dose, dose 1 for COVID-19 vaccination. The patient had an allergy to nickel.  The patient was not pregnant at the time of vaccination.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were unknown. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Jan2021 at 06:30 PM, the patient experienced soreness of injection site. The patient did not receive any treatment for the events. The clinical outcome of soreness of injection site was  not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Shakiness-Severe, Additional Details: patient went unresponsive within 10 minutes of vaccine during monitoring period, with faint pulse and shakiness for more than 90 second. she became responive, and started to feel better. EMS arrived, checked her out, and found all vitals were normal and she declined trip to ER. She followed up with MD she said at check up phone call and was advised not to get 2nd covid shot
This spontaneous report as received from a mother of a patient via a nurse practitioner, via a field representative refers to a male child of an unknown age. The patient's concurrent conditions and medical history were not reported. On an unspecified date (reported as recently), the patient was vaccinated with a dose of an unidentified Merck Human Papillomavirus (HPV) vaccine (name, lot number, expiration date and dose were not provided) intramuscularly. The nurse practitioner stated that the injection was not given in her office. Concomitant therapies were not reported. The nurse practitioner stated that the patient's mother informed her that after the injection, the child experienced a "psychotic episode" (onset date not specified). The patient's mother sought medical attention by visiting the provider's office. The outcome of the event was not reported. The reporters did not provide the causality assessment between the suspect therapy and the event. Additional information has been requested.
Face allergy side effect and experiencing face swelling; Face allergy side effect and experiencing face swelling; This is a spontaneous report from a contactable consumer or other non-health care professional(reporting for mother). A 44-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: FA7484) via an unspecified route of administration, on 25Jul2021 15:00 (at the age of 44-years-old) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. No investigation assessment. No prior vaccination within 4 weeks. On an unspecified date, after the shot the patient had an allergy, she did tell the Pharmacist after the vaccine; but she did not explain like a face allergy side effect one of the allergic symptoms. She was experiencing face swelling. Reporter want to know if she can take Zyrtec for her allergy. The outcome of the events was unknown.  Follow-up attempts were completed. No further information was expected.
Immediately after shot I felt nauseous and sore arm was nauseated for 3 hours after. My arm got progressively more sore throughout the night, I took a hot bath w/o relief and took some Tylenol just to get to bed the next day it was still sore and the injections today it was hot the end of the next day I noticed I had blotchy red hot spots on my arm near the injection site
tested positive for COVID-19 after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID-19 after vaccination) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced COVID-19 (tested positive for COVID-19 after vaccination). At the time of the report, COVID-19 (tested positive for COVID-19 after vaccination) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were provided by reporter  No treatment information was provided.
INJECTION SITE PAIN; SWOLLEN LYMPH NODES; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On JUL-2021, the patient experienced swollen lymph nodes. On SEP-2021, the patient experienced injection site pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the injection site pain and swollen lymph nodes was not reported. This report was non-serious.
Received Pediarix, Prevnar and Rotateq on 7/2/08.  Developed vomiting and diarrhea on 7/3/08.  Seen in Emergency Room that night and given Zofran.  Exam was normal.  Seen in clinic today on 7/7/08; exam was normal.  Mom and Grandma with same symptoms that began on 7/4/08; unsure if this illness connected with vaccines.
Heart palpitations dizziness /or lightheadedness  Assisted to reclining chair vitals  done and normal. Rested about 20 more minutes and fine.
After both vaccinations for COVID-19 (Moderna: First dose - 4/15/2021, Second dose (05/18/2021, I experienced swollen lymph nodes in my armpit and collarbone on the vaccinated side of my body (Right side). Swelling of lymph nodes occurred around 18-24hrs after the vaccination and remained for about 5-7 days. This swelling resulted in varying levels of discomfort (worse in the days shortly after vaccination) when engaging the muscles and tendons around my armpit, feeling like the lymph node was being ?pulled?. Around 2 months after second vaccination (today), there is no pain or discomfort, but I can still feel the lymph node in my right armpit versus being unable to in my left armpit.
On Friday night I noticed my knees were itching terribly.  After about an hour, I noticed little swellings all over my body.  Taking 2 Benadryl eliminated the itchiness within 45 minutes.  After 48 hours, the itchiness still continues, and the Benadryl continues to eliminate the itching.
patients administered Moderna vaccine while temperature excursion assessment was ongoing; patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients administered Moderna vaccine while temperature excursion assessment was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients administered Moderna vaccine while temperature excursion assessment was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients administered Moderna vaccine while temperature excursion assessment was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.   This case was linked to MOD-2022-501575 (Patient Link).
Admissions diagnosis: Acute hypoxic Respiratory failure Admitted 12/28/21 - 12/29/21. 77-year-old male with a past medical history significant for non-small cell adenocarcinoma of the lung s/p chemotherapy/XRT now on immunotherapy, COPD, moderate aortic stenosis, HTN, HLD, BPH who presents with acute hypoxic respiratory failure secondary to COVID-19, receiving booster 9/29/2021. He has no known exposure to COVID-19, however to found to have AHRF with exertion in ED with desaturation to 88%. Also suspect concurrent COPD exacerbation with his hemoptysis and increased albuterol use. Immunotherapy pneumonitis possible but no evidence of pneumonitis on CT chest on admission. No PE or lung infiltrates noted on CT chest. Patient was treated with dexamethasone 6mh daily and remdesivir 200 IV x1 and then 100 IV daily, as well as azithromycin 500mg IV daily. On discharge, patient was satting well on Room Air, and walk test was within normal limits. Vaccination history: Date Immunization Series 09/29/2021 COVID-19 (PFIZER), MRNA, LNP-S, PF, 30 MCH/0 3 02/27/2021 COVID-19 (PFIZER), MRNA, LNP-S, PF, 30 MCG/0 3 02/06/2021 COVID-19 (PFIZER), MRNA, LNP-S, PF, 30 MCG/01
Chest discomfort -pressure. Slight headache. Feverish - symptoms lasted about 2 hrs.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's concurrent condition, medical history or concomitant medications were not reported. The nurse reported that on 24-FEB-2015, the patient was vaccinated with improperly stored RECOMBIVAX HB lot # K009953, expiry date 03-APR-2016 (dose and route of administration unspecified). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Slight fever not sure of reading, swollen arm from Tuesday to late Sat. Nausea, very ill that night. Felt ill until Friday.
Syncope - school nurse reported twitching/fine motor seizure questioned. Evaluated/released by Emergency room.   12/4/09:  ED Record received for date of service 11/13/09.  Dx:  Syncope.  Received H1N1 Vaccine and experienced syncope with questionable seizure like activity.  C/O R arm and hand pain, chills and HA.
Dysarthria, tremor and inability to control the right hand.  Brain MRI findings of increased signal intensity in the  bilateral putamen and thalami